Hexo Corp (HEXO) |
|
0.5076 -0.01 (-2.01%)
|
04-09 16:02 |
|
Open: |
0.54 |
Pre. Close: |
0.518 |
|
High:
|
0.531 |
Low:
|
0.5009 |
|
Volume:
|
11,989,527 |
Market Cap:
|
141M |
|
|
|
|
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. HEXO Corp. is headquartered in Gatineau, Canada. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.541 - 0.545 |
0.545 - 0.548 |
|
Low:
|
0.491 - 0.496 |
0.496 - 0.499 |
|
Close:
|
0.504 - 0.511 |
0.511 - 0.516 |
|
Technical analysis |
as of: 2020-04-09 4:31:17 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.04 One year: 1.44 |
| Support: |
Support1: 0.35 Support2: 0.29 |
| Resistance: |
Resistance1: 0.89 Resistance2: 1.23 |
| Pivot: |
0.73  |
| Moving Average: |
MA(5): 0.62 MA(20): 0.69
MA(100): 1.41 MA(250): 3.46 |
| MACD: |
MACD(12,26): -0.11 Signal(9): -0.11 |
| Stochastic oscillator: |
%K(14,3): 19.71 %D(3): 30.00 |
| RSI: |
RSI(14): 36.89 |
| 52-week: |
High: 8.40 Low: 0.35 Change(%): -92.0 |
| Average Vol(K): |
3-Month: 557403 10-Days: 881368 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.HEXO has closed above bottom band by 14.2%. Bollinger Bands are 5.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2020-04-01
Analysts Cut Target Prices after HEXO's Q2 Earnings - Market Realist
Hexo (TSE:HEXO) reported its second-quarter earnings on March 30. For the quarter, the company missed analysts' revenue expectations marginally.
2020-03-31
Hexo Analysts Project Continued Underperformance After Q2 Report
Consumer packaged goods company HEXO Corp. (TSX: HEXO) (NYSE: HEXO ) released its second-quarter financial results Monday, posting net revenue of CA$17 million ($12.01 million), a 17% quarter-over-quarter increase. The company reported a quarterly net loss of CA$298.2 million versus a loss of CA$4.3 million in the same quarter of 2019. The HEXO Analysts Cantor Fitzgerald's Pablo Zuanic maintained an Underweight rating on Hexo with a price target of CA$0.72 (51 cents). BofA Securities’ Christopher Carey resumed an Underperform rating on the stock with a CA$1 price objective. Cantor Sees Important Issue In Hexo’s Lack Of Improvement In Cash Burn The most important factors in Hexo's second-quarter report were: no improvement in cash burn, lower gross profit per gram and worsening operating cash flow/sales ratios, Zuanic said in a Monday note. Considering that the company’s operating cash flow worsened while its adjusted EBITDA figures improved, the analyst suggested that adjusted EBITDA shouldn’t be used to …
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Specialty Generic |
| Shares Out. (M) |
284.12 |
| Shares Float (M) |
242.52 |
|
% Held by Insiders
|
6.09 |
|
% Held by Institutions
|
14.19 |
|
Shares Short (K)
|
31330 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
Book Value (p.s.)
|
|
|
PEG Ratio
|
|
|
Profit Margin
|
-207.21 |
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-13.0 |
|
Return on Equity (ttm)
|
-21.1 |
|
Qtrly Rev. Growth
|
156.0 |
|
Gross Profit (p.s.)
|
0.086 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
|
|
P/E Growth Ratio
|
|
|
P/BV
|
|
|
P/S
|
|
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
